Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated

Treatment and Recovery: Managing Your Care

At a Glance

Boutonneuse fever is highly treatable with prompt antibiotic therapy. The gold standard treatment is doxycycline, which rapidly clears the infection and is safe for children in short courses. Early treatment is crucial to prevent severe vascular complications.

Boutonneuse fever is a highly treatable infection, and the vast majority of patients recover completely when they receive the right care promptly [1][2]. Treatment focuses on using specific antibiotics that can enter your cells to eliminate the Rickettsia conorii bacteria.

The Gold Standard: Doxycycline

Doxycycline is the first-line treatment for Boutonneuse fever [1][3]. It is a type of tetracycline antibiotic that is uniquely effective at stopping the growth of rickettsial bacteria.

  • How it works: Doxycycline prevents the bacteria from producing the proteins they need to replicate [1].
  • Speed of recovery: Most patients see a significant improvement within 24 to 72 hours of starting the medication [4]. Your fever will typically break quickly once the drug begins to work [5].
  • Standard course: While your doctor will determine the exact duration, the medication is usually taken for several days until the fever has been gone for at least 48 hours [3].

Treatment for Children and Pregnant Women

Safety is a priority when choosing medications for specific populations.

Children

Historically, there were concerns that tetracycline antibiotics could cause permanent staining of children’s teeth. However, modern research has shown that short courses of doxycycline (less than 21 days) do not cause dental staining [3][6]. Consequently, doxycycline is the recommended treatment for children of all ages with Boutonneuse fever [3][7].

Pregnant Women

Because doxycycline is generally avoided during pregnancy, alternative antibiotics called macrolides are usually prescribed.

  • Common alternatives: Your doctor may prescribe josamycin or clarithromycin [8][9].
  • Note on severe cases: If the infection is severe or life-threatening, your doctor may still choose to prescribe doxycycline. The risk to the mother’s life in complicated spotted fevers can sometimes outweigh the theoretical risks to the baby [1].

Managing Potential Complications

While most cases are mild, about 5–10% of patients may develop severe complications [10]. These risks are higher for the elderly or those with underlying health conditions, such as G6PD deficiency, diabetes, or heart disease [11][12].

Warning Signs of Severe Disease

It is critical to seek immediate medical attention if you notice any of the following “red flag” symptoms [13][14]:

  • Shortness of breath: This can indicate Acute Respiratory Distress Syndrome (ARDS), a condition where the lungs become inflamed [14][13].
  • Chest pain or irregular heartbeat: This may suggest myocarditis (inflammation of the heart muscle) [14].
  • Confusion or severe headache: These can be signs of encephalitis (inflammation of the brain) [13].
  • Decreased urination: This can signal that the kidneys are being affected (part of multi-organ failure) [14].
  • Vision changes: Rickettsia can cause inflammation in the eyes, such as retinitis or macular edema [15][16].

Why Early Treatment Matters

The single most important factor in preventing these complications is early initiation of antibiotics [10]. Delaying treatment increases the risk of the bacteria spreading and causing more widespread vascular damage [14][17]. If your doctor suspects Boutonneuse fever, they will often start you on doxycycline immediately, even before lab results confirm the diagnosis [10][7].

Common questions in this guide

How is Boutonneuse fever treated?
The most effective treatment is an antibiotic called doxycycline. It stops the bacteria from multiplying, and most patients see their fever break and symptoms significantly improve within 24 to 72 hours of starting the medication.
Is doxycycline safe for children with Boutonneuse fever?
Yes, modern research shows that short courses of doxycycline (less than 21 days) are safe for children and do not cause permanent dental staining. It is the recommended treatment for children of all ages.
What antibiotics are safe during pregnancy for Boutonneuse fever?
Pregnant women are typically prescribed alternative antibiotics called macrolides, such as josamycin or clarithromycin. However, in severe or life-threatening cases, a doctor may still determine that doxycycline is necessary.
What are the warning signs of a severe infection?
Seek immediate medical care if you develop shortness of breath, chest pain, an irregular heartbeat, severe headache, confusion, vision changes, or decreased urination. These red flags can signal dangerous complications affecting your major organs.
Why is it important to start treatment early?
Starting antibiotics as soon as possible is the single most important factor in preventing severe complications and widespread blood vessel damage. Doctors often start treatment immediately if they suspect the infection, even before lab results return.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are we starting doxycycline immediately, and at what dosage?
  2. 2.(If for a child) I’ve heard about dental staining with tetracyclines; can you confirm why a short course of doxycycline is considered safe for my child?
  3. 3.(If pregnant) Is josamycin or clarithromycin the best alternative for me, and are there any risks to the baby I should know about?
  4. 4.What specific 'red flag' symptoms should I monitor at home that would indicate a complication is developing?
  5. 5.How will we monitor my progress to ensure the infection is clearing as expected?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Mediterranean Spotted Fever: Current Knowledge and Recent Advances.

    Spernovasilis N, Markaki I, Papadakis M, et al.

    Tropical medicine and infectious disease 2021; (6(4)) doi:10.3390/tropicalmed6040172.

    PMID: 34698275
  2. 2

    Challenges in Diagnosing Rickettsial Infection: A Case Report of Rickettsia conorii in a Pediatric Patient in Iran.

    Hosseininasab A, Latifian M, Jamallpour H, et al.

    The Pediatric infectious disease journal 2025; (44(8)):e305-e306 doi:10.1097/INF.0000000000004799.

    PMID: 40073389
  3. 3

    Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety.

    Stultz JS, Eiland LS

    The Annals of pharmacotherapy 2019; (53(11)):1162-1166 doi:10.1177/1060028019863796.

    PMID: 31280586
  4. 4

    A case of uveitis due to Rickettsia conorii infection in Southeastern France.

    Caisso C, Payan J, Dunais B, et al.

    Ticks and tick-borne diseases 2016; (7(2)):338-41.

    PMID: 26711674
  5. 5

    Serum C-reactive protein and procalcitonin values in acute Q fever, scrub typhus, and murine typhus.

    Lin IF, Lin JN, Tsai CT, et al.

    BMC infectious diseases 2020; (20(1)):334 doi:10.1186/s12879-020-05058-8.

    PMID: 32398008
  6. 6

    Dental staining after doxycycline use in children.

    Pöyhönen H, Nurmi M, Peltola V, et al.

    The Journal of antimicrobial chemotherapy 2017; (72(10)):2887-2890 doi:10.1093/jac/dkx245.

    PMID: 29091225
  7. 7

    Prospective Cohort Study of Single-Day Doxycycline Therapy for Mediterranean Spotted Fever.

    Espejo E, Andrés M, Garcia MC, et al.

    Antimicrobial agents and chemotherapy 2018; (62(11)) doi:10.1128/AAC.00978-18.

    PMID: 30150470
  8. 8

    Randomized Trial of Clarithromycin for Mediterranean Spotted Fever.

    Anton E, Muñoz T, Travería FJ, et al.

    Antimicrobial agents and chemotherapy 2015; (60(3)):1642-5 doi:10.1128/AAC.01814-15.

    PMID: 26711765
  9. 9

    Macrophagic activation syndrome related to an infection by Rickettsia conorii in a child.

    Hsairi M, Ben Ameur S, Alibi S, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(10)):1076-1079 doi:10.1016/j.arcped.2016.07.008.

    PMID: 27642144
  10. 10

    [Mediterranean Spotted Fever: Retrospective Review of Hospitalized Cases and Predictive Factors of Severe Disease].

    Meireles M, Magalhães R, Guimas A

    Acta medica portuguesa 2015; (28(5)):624-31.

    PMID: 26667867
  11. 11

    Severe Israeli spotted fever with multiorgan failure in a child.

    Bota S, de Sousa R, Santos M, et al.

    Ticks and tick-borne diseases 2016; (7(5)):663-664 doi:10.1016/j.ttbdis.2016.02.013.

    PMID: 26905298
  12. 12

    Fatal Case of Mediterranean Spotted Fever Associated with Septic Shock, Iran.

    Esmaeili S, Latifian M, Khalili M, et al.

    Emerging infectious diseases 2022; (28(2)):485-488 doi:10.3201/eid2802.211023.

    PMID: 35076374
  13. 13

    Spotted fever rickettsioses causing myocarditis and ARDS: a case from Sri Lanka.

    Herath HMLY, Jayasundara JMHD, Senadhira SDN, et al.

    BMC infectious diseases 2018; (18(1)):705 doi:10.1186/s12879-018-3631-6.

    PMID: 30594148
  14. 14

    A Rare Case of Mediterranean Spotted Fever and Encephalitis.

    Sousa Almeida R, Pego PM, Pinto MJ, Matos Costa J

    Case reports in infectious diseases 2016; (2016()):2421540 doi:10.1155/2016/2421540.

    PMID: 28053795
  15. 15

    Ocular manifestations of rickettsia in children: common but frequently overlooked.

    Marques SHM, Guerra MG, Almeida C, Ribeiro M

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-222809.

    PMID: 29776935
  16. 16

    Mediterranean spotted fever with multiorgan involvement.

    Davis K, Ahmado A, Warrell CE, et al.

    BMJ case reports 2022; (15(12)) doi:10.1136/bcr-2022-249426.

    PMID: 36543366
  17. 17

    Leptospirosis with Indian Tick-borne Typhus Coinfection: A Rare Presentation of Tropical Febrile Illness.

    Mitra S, Bavishi A, Muley A, Marathe A

    The Journal of the Association of Physicians of India 2024; (72(10)):e25-e27 doi:10.59556/japi.72.0694.

    PMID: 39390877

This page provides educational information about Boutonneuse fever treatments and recovery. It is not a substitute for professional medical advice, diagnosis, or treatment from your healthcare provider.

Get notified when new evidence is published on Boutonneuse fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.